IMPINJ INC·4

Jun 9, 5:00 PM ET

DIORIO CHRIS PH.D. 4

4 · IMPINJ INC · Filed Jun 9, 2026

Research Summary

AI-generated summary of this filing

Updated

Impinj CEO Chris Diorio Exchanges 180,000 Shares

What Happened
Chris Diorio, CEO of Impinj (PI), reported a simultaneous acquisition and disposition of 180,000 shares on May 26, 2026. The Form 4 shows an "other acquisition or disposition (J)" for 180,000 shares at $156.68 per share (total reported value $28,201,500) and a matching disposition of 180,000 shares at the same per‑share value. According to the filing footnote, this was an estate‑planning exchange with the 2012 Diorio Descendants Irrevocable Trust; the exchange used an estimated per‑share value of $156.675 (the day’s average price).

Key Details

  • Transaction date: May 26, 2026. Report filed: June 9, 2026 (appears to be filed late relative to the trade date).
  • Reported price: $156.68 per share (filing); footnote states $156.675 (average of high/low).
  • Shares exchanged: 180,000 acquired from the Diorio Trust and 180,000 transferred to the Diorio Trust; reported total value ≈ $28.2M for each leg.
  • Shares owned after transaction: not specified in the filing.
  • Notable footnotes: F1 — exchange for estate‑planning purposes with the 2012 Diorio Descendants Irrevocable Trust; F2 — transactions were effected under a Rule 10b5‑1 trading plan adopted Feb 23, 2026.

Context
This was an exchange between Dr. Diorio and a family trust for estate planning, executed under a preexisting 10b5‑1 plan. Because the same number of shares were received and transferred, the transaction does not change the insider’s net share count and therefore is not a straightforward buy or sell that signals a change in conviction. The late filing may be noteworthy for compliance tracking but the filing itself attributes the movement to estate planning and a prearranged plan.

Insider Transaction Report

Form 4
Period: 2026-05-26
DIORIO CHRIS PH.D.
DirectorCHIEF EXECUTIVE OFFICER
Transactions
  • Other

    Common Stock

    [F1][F2]
    2026-05-26$156.68/sh+180,000$28,201,500570,302 total
  • Other

    Common Stock

    [F1][F2]
    2026-05-26$156.68/sh180,000$28,201,500390,302 total
Holdings
  • Common Stock

    (indirect: by DFT L.L.C.)
    199,362
Footnotes (2)
  • [F1]For estate planning purposes, on May 26, 2026 (the "Transfer Date"), Dr. Chris Diorio ("Dr. Diorio") received 180,000 shares of the issuer's common stock from the 2012 Diorio Descendants Irrevocable Trust (the "Diorio Trust") in exchange for the simultaneous transfer by Dr. Diorio of 180,000 shares of the issuer's common stock to the Diorio Trust. The estimated per-share value was $156.675, the average of the high and low sales prices of a share of the issuer's common stock on the Transfer Date.
  • [F2]The exchange of shares reported by Dr. Diorio was effected pursuant to a Rule 10b5-1 trading plan adopted on February 23, 2026.
Signature
/s/ Yukio Morikubo, Attorney in fact for Chris Diorio|2026-06-09

Documents

1 file
  • 4
    form4-06092026_050601.xmlPrimary